Comments
Drug discovery firm Sun Pharma Advanced Research Company (SPARC) on Tuesday said it has posted a net loss of Rs 18.32 crore for the first quarter ended June 30, 2012, compared with a net loss of Rs 11.26 crore over the same period of previous fiscal.
Total income of the company declined to Rs 6.38 crore for the current quarter, as against Rs 10.08 crore during the corresponding period of previous year.
Shares of SPARC today closed at Rs 74.55 on the BSE, up 1.43 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.